Paediatric ovarian (usually germ-cell) tumour staging.
The Ovarian Tumour — Toronto / FIGO Stage is a oncology scoring tool used in paediatric practice. Paediatric ovarian (usually germ-cell) tumour staging. It scores 1 criteria and interprets the total across 4 bands, so the number always arrives with the severity it implies rather than on its own. In PediAid each criterion is shown as a labelled option with the weight it carries, so the total can be checked rather than taken on trust.
1. They are Extent of disease.
The total is interpreted as: 1 stage or more - Stage I: stage I - surgery alone with surveillance is often sufficient for germ-cell tumours; excellent prognosis; 2 stage or more - Stage II: stage II - surgery plus platinum-based chemotherapy; 3 stage or more - Stage III: stage III - surgery plus chemotherapy; monitor tumour markers (AFP, β-hCG) for response; 4 stage or more - Stage IV: stage IV - distant metastases. Platinum-based chemotherapy; germ-cell tumours remain highly curable even at this stage.
No. It is a structured way to record and communicate severity. A clinician concerned about a child should act on that concern regardless of the total.
Source: Gupta S, Aitken JF, Bartels U et al. Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. Lancet Oncol 2016;17:e163-72.
Yes. Score definitions are bundled with the PediAid app, so the score computes without a connection.